Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer

被引:351
作者
Hart, Phil A. [1 ]
Bellin, Melena D. [3 ,4 ]
Andersen, Dana K. [5 ]
Bradley, David [2 ]
Cruz-Monserrate, Zobeida [1 ]
Forsmark, Christopher E. [6 ]
Goodarzi, Mark O. [7 ]
Habtezion, Aida [9 ]
Korc, Murray [10 ,11 ,12 ,13 ]
Kudva, Yogish C. [14 ]
Pandol, Stephen J. [8 ]
Yadav, Dhiraj [16 ,17 ]
Chari, Suresh T. [15 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH 43210 USA
[2] Ohio State Univ, Wexner Med Ctr, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA
[3] Univ Minnesota, Div Pediat Endocrinol, Med Ctr, Minneapolis, MN USA
[4] Univ Minnesota, Schulze Diabet Inst, Med Ctr, Minneapolis, MN USA
[5] NIDDK, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA
[6] Univ Florida, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA
[7] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA
[8] Cedars Sinai Med Ctr, Dept Vet Affairs, Los Angeles, CA 90048 USA
[9] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
[10] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA
[11] Indiana Univ Sch Med, Dept Biochem, Indianapolis, IN 46202 USA
[12] Indiana Univ Sch Med, Dept Mol Biol, Indianapolis, IN 46202 USA
[13] Indiana Univ, Simon Canc Ctr, Pancreat Canc Signature Ctr, Indianapolis, IN USA
[14] Mayo Clin, Div Endocrinol & Metab, Rochester, MN USA
[15] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[16] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
[17] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
来源
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2016年 / 1卷 / 03期
关键词
HEPATIC INSULIN-RESISTANCE; ISLET AMYLOID POLYPEPTIDE; BETA-CELL FUNCTION; GLUCOSE-METABOLISM; RISK-FACTORS; KAPPA-B; HEREDITARY PANCREATITIS; GLYCEMIC CONTROL; NATURAL-HISTORY; PREVALENCE;
D O I
10.1016/S2468-1253(16)30106-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Diabetes mellitus is a group of diseases defined by persistent hyperglycaemia. Type 2 diabetes, the most prevalent form, is characterised initially by impaired insulin sensitivity and subsequently by an inadequate compensatory insulin response. Diabetes can also develop as a direct consequence of other diseases, including diseases of the exocrine pancreas. Historically, diabetes due to diseases of the exocrine pancreas was described as pancreatogenic or pancreatogenous diabetes mellitus, but recent literature refers to it as type 3c diabetes. It is important to note that type 3c diabetes is not a single entity; it occurs because of a variety of exocrine pancreatic diseases with varying mechanisms of hyperglycaemia. The most commonly identified causes of type 3c diabetes are chronic pancreatitis, pancreatic ductal adenocarcinoma, haemochromatosis, cystic fibrosis, and previous pancreatic surgery. In this Review, we discuss the epidemiology, pathogenesis, and clinical relevance of type 3c diabetes secondary to chronic pancreatitis and pancreatic ductal adenocarcinoma, and highlight several important knowledge gaps.
引用
收藏
页码:226 / 237
页数:12
相关论文
共 132 条
[1]   Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common Cancers [J].
Aggarwal, Gaurav ;
Kamada, Pratima ;
Chari, Suresh T. .
PANCREAS, 2013, 42 (02) :198-201
[2]   Adrenomedullin is Up-regulated in Patients With Pancreatic Cancer and Causes Insulin Resistance in β Cells and Mice [J].
Aggarwal, Gaurav ;
Ramachandran, Vijaya ;
Javeed, Naureen ;
Arumugam, Thiruvengadam ;
Dutta, Shamit ;
Klee, George G. ;
Klee, Eric W. ;
Smyrk, Thomas C. ;
Bamlet, William ;
Han, Jing Jing ;
Vittar, Natalia B. Rumie ;
De Andrade, Mariza ;
Mukhopadhyay, Debabrata ;
Petersen, Gloria M. ;
Fernandez-Zapico, Martin E. ;
Logsdon, Craig D. ;
Chari, Suresh T. .
GASTROENTEROLOGY, 2012, 143 (06) :1510-+
[3]   New-onset diabetes in pancreatic cancer: A study in the primary care setting [J].
Aggarwal, Gaurav ;
Rabe, Kari G. ;
Petersen, Gloria M. ;
Chari, Suresh T. .
PANCREATOLOGY, 2012, 12 (02) :156-161
[4]   13. Diabetes Care in the Hospital [J].
不详 .
DIABETES CARE, 2016, 39 :S99-S104
[5]   B-CELL FUNCTION IN PATIENTS WITH CHRONIC-PANCREATITIS AND ITS RELATION TO EXOCRINE PANCREATIC FUNCTION [J].
ANDERSEN, BN ;
KRARUP, T ;
PEDERSEN, NT ;
FABER, OK ;
HAGEN, C ;
WORNING, H .
DIABETOLOGIA, 1982, 23 (02) :86-89
[6]  
Andersen DK, 2013, PANCREAS, V42, P1227, DOI 10.1097/MPA.0b013e3182a9ad9d
[7]   Cytokine-induced inhibition of insulin release from mouse pancreatic β-cells deficient in inducible nitric oxide synthase [J].
Andersson, AK ;
Flodström, M ;
Sandler, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (02) :396-403
[8]   Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes [J].
Basso, D ;
Millino, C ;
Greco, E ;
Romualdi, C ;
Fogar, P ;
Valerio, A ;
Bellin, M ;
Zambon, CF ;
Navaglia, F ;
Dussini, N ;
Avogaro, A ;
Pedrazzoli, S ;
Lanfranchi, G ;
Plebani, M .
GUT, 2004, 53 (08) :1159-1166
[9]   Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide [J].
Basso, D ;
Valerio, A ;
Seraglia, R ;
Mazza, S ;
Piva, MG ;
Greco, E ;
Fogar, P ;
Gallo, N ;
Pedrazzoli, S ;
Tiengo, A ;
Plebani, M .
PANCREAS, 2002, 24 (01) :8-14
[10]   BETA-CELL FUNCTION IN PANCREATIC ADENOCARCINOMA [J].
BASSO, D ;
PLEBANI, M ;
FOGAR, P ;
DELFAVERO, G ;
BRIANI, G ;
MEGGIATO, T ;
PANOZZO, MP ;
FERRARA, C ;
DANGELI, F ;
BURLINA, A .
PANCREAS, 1994, 9 (03) :332-335